Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial

Jonathan A Silversides^{1

2}, Ross McMullan³, Lydia M Emerson⁴, Ian Bradbury⁵, Jonathan Bannard-Smith^{6

7}, Tamas Szakmany^{8

9}, John Trinder¹⁰, Anthony J Rostron^{11

12}, Paul Johnston¹³, Andrew J Ferguson³, Andrew J Boyle^{3

14

13}, Bronagh Blackwood¹⁴, John C Marshall^{15

16}, Daniel F McAuley^{3

14}

Affiliations

¹ Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK. j.silversides@qub.ac.uk.
² Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK. j.silversides@qub.ac.uk.
³ Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK.
⁴ School of Health Sciences, City, University of London, London, UK.
⁵ Independent Consulting Statistician, Aviemore, UK.
⁶ Department of Critical Care, Manchester University NHS Foundation Trust, Manchester, UK.
⁷ Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
⁸ Critical Care Directorate, Aneurin Bevan University Health Board, Newport, UK.
⁹ Department of Anaesthesia, Intensive Care and Pain Medicine, Cardiff University, Cardiff, UK.
¹⁰ Intensive Care Unit, South-Eastern Health and Social Care Trust, Dundonald, UK.
¹¹ Integrated Critical Care Unit, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
¹² Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
¹³ Intensive Care Unit, Northern Health and Social Care Trust, Antrim, UK.
¹⁴ Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK.
¹⁵ Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, Canada.
¹⁶ Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada.

PMID: 37642672
DOI: 10.1007/s00134-023-07174-w

Published Erratum

Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial

Jonathan A Silversides et al. Intensive Care Med. 2023 Nov.

. 2023 Nov;49(11):1440.

doi: 10.1007/s00134-023-07174-w.

Authors

Affiliations

¹ Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK. j.silversides@qub.ac.uk.
² Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK. j.silversides@qub.ac.uk.
³ Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK.
⁴ School of Health Sciences, City, University of London, London, UK.
⁵ Independent Consulting Statistician, Aviemore, UK.
⁶ Department of Critical Care, Manchester University NHS Foundation Trust, Manchester, UK.
⁷ Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
⁸ Critical Care Directorate, Aneurin Bevan University Health Board, Newport, UK.
⁹ Department of Anaesthesia, Intensive Care and Pain Medicine, Cardiff University, Cardiff, UK.
¹⁰ Intensive Care Unit, South-Eastern Health and Social Care Trust, Dundonald, UK.
¹¹ Integrated Critical Care Unit, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
¹² Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
¹³ Intensive Care Unit, Northern Health and Social Care Trust, Antrim, UK.
¹⁴ Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK.
¹⁵ Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, Canada.
¹⁶ Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada.

PMID: 37642672
DOI: 10.1007/s00134-023-07174-w

No abstract available

PubMed Disclaimer

Erratum for

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial.
Silversides JA, McMullan R, Emerson LM, Bradbury I, Bannard-Smith J, Szakmany T, Trinder J, Rostron AJ, Johnston P, Ferguson AJ, Boyle AJ, Blackwood B, Marshall JC, McAuley DF. Silversides JA, et al. Intensive Care Med. 2022 Feb;48(2):190-200. doi: 10.1007/s00134-021-06596-8. Epub 2021 Dec 16. Intensive Care Med. 2022. PMID: 34913089 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial

Affiliations

Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources